Literature DB >> 32270226

Percutaneous thermal ablation for treatment of osteoid osteoma: a systematic review and analysis.

Will S Lindquester1, John Crowley2, C Matthew Hawkins3,4.   

Abstract

OBJECTIVE: Although radiofrequency ablation is well validated for treatment of osteoid osteoma, newer technologies, namely cryoablation, have been less thoroughly studied. The purpose is to perform a systematic review and pooled analysis of percutaneous ablation technologies for treatment of osteoid osteoma with subset analysis of intra-articular and spinal tumors.
MATERIAL AND METHODS: A total of 36 of 79 identified manuscripts met inclusion criteria, comprising 1863 ablations in 1798 patients. Inclusion criteria were (1) retrospective or prospective analysis of thermal ablation of osteoid osteomas in any location, (2) at least 6 months of clinical follow-up, (3) 10 or more patients, (4) patients not included in a second study included in this review, and (5) English language or English translation available. Success rate was defined as all ablations minus technical failures, clinical failures, and recurrences. Subset analysis of intra-articular and spinal tumors was performed.
RESULTS: Overall success rate was 91.9% (95% CI 91-93%). Technical failure, clinical failure, and recurrence rates were 0.3%, 2.1%, and 5.6% respectively. Complications were seen in 2.5% (95% CI 1.9-3.3%) patients. There was no significant difference when comparing radiofrequency ablation and cryoablation (p = 0.92). Success rates for intra-articular (radiofrequency ablation) and spinal tumors (radiofrequency and cryoablation) were 97% and 91.6% respectively.
CONCLUSION: Percutaneous ablation of osteoid osteomas was highly successful with low complication rates. Efficacy of radiofrequency ablation and cryoablation is similar, which is consequential because cryoablation is associated with decreased pain, predictable nerve regeneration, and theoretical immunotherapy benefits. Treatment of more challenging intra-articular and spinal lesions demonstrated similarly high success and low complication rates.

Entities:  

Keywords:  Bone tumor; Cryoablation; Meta-analysis; Microwave ablation; Osteoid osteoma; Percutaneous ablation; Radiofrequency ablation

Mesh:

Year:  2020        PMID: 32270226     DOI: 10.1007/s00256-020-03435-7

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  40 in total

1.  Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment.

Authors:  M A Simon
Journal:  J Bone Joint Surg Am       Date:  1999-03       Impact factor: 5.284

Review 2.  Osteoid osteoma treated by percutaneous thermal ablation: when do we fail? A systematic review and guidelines for future reporting.

Authors:  Ezio Lanza; Yann Thouvenin; Pierre Viala; Luca Maria Sconfienza; Dario Poretti; Gianpaolo Cornalba; Francesco Sardanelli; Catherine Cyteval
Journal:  Cardiovasc Intervent Radiol       Date:  2013-12-13       Impact factor: 2.740

3.  [CT-controlled thermocoagulation of osteoid osteoma in comparison with traditional methods].

Authors:  N J Lindner; M Scarborough; J M Ciccarelli; W F Enneking
Journal:  Z Orthop Ihre Grenzgeb       Date:  1997 Nov-Dec

4.  Radiofrequency ablation for non-spinal osteoid osteomas in 557 patients.

Authors:  Eugenio Rimondi; Andreas F Mavrogenis; Giuseppe Rossi; Rosanna Ciminari; Cristina Malaguti; Cristina Tranfaglia; Daniel Vanel; Pietro Ruggieri
Journal:  Eur Radiol       Date:  2011-08-14       Impact factor: 5.315

5.  Cryoablation of osteoid osteoma: two case reports.

Authors:  David M Liu; Stephen T Kee; Christopher T Loh; Justin McWilliams; Stephen G Ho; Jayson S Brower; Peter L Munk
Journal:  J Vasc Interv Radiol       Date:  2010-02-06       Impact factor: 3.464

6.  Microwave ablation of osteoid osteomas using dynamic MR imaging for early treatment assessment: preliminary experience.

Authors:  Michael Kostrzewa; Patricius Diezler; Henrik Michaely; Nils Rathmann; Ulrike I Attenberger; Stefan O Schoenberg; Steffen J Diehl
Journal:  J Vasc Interv Radiol       Date:  2013-11-26       Impact factor: 3.464

7.  The use of microwaves ablation in the treatment of epiphyseal osteoid osteomas.

Authors:  Antonio Basile; Giovanni Failla; Angelo Reforgiato; Giovanni Scavone; Elena Mundo; Martina Messina; Giuseppe Caltabiano; Francesco Arena; Viola Ricceri; Antonio Scavone; Salvatore Masala
Journal:  Cardiovasc Intervent Radiol       Date:  2013-08-30       Impact factor: 2.740

8.  Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment.

Authors:  D I Rosenthal; F J Hornicek; M W Wolfe; L C Jennings; M C Gebhardt; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1998-06       Impact factor: 5.284

Review 9.  The management of osteoid osteoma: updates and controversies.

Authors:  Ismat Ghanem
Journal:  Curr Opin Pediatr       Date:  2006-02       Impact factor: 2.856

Review 10.  Cryoablation and immunotherapy: an overview of evidence on its synergy.

Authors:  B M Aarts; E G Klompenhouwer; S L Rice; F Imani; T Baetens; A Bex; S Horenblas; M Kok; J B A G Haanen; R G H Beets-Tan; F M Gómez
Journal:  Insights Imaging       Date:  2019-05-20
View more
  11 in total

Review 1.  Radiofrequency ablation is as safe and effective as surgical excision for spinal osteoid osteoma: a systematic review and meta-analysis.

Authors:  Alessandro Sangiorgio; Lorenzo Massimo Oldrini; Christian Candrian; Costantino Errani; Giuseppe Filardo
Journal:  Eur Spine J       Date:  2022-10-10       Impact factor: 2.721

2.  Gene expression profiling utilizing extremely sensitive CDNA arrays and enrichment-based network study of major bone cancer genes.

Authors:  Qiang Lin; Anum Munir; Sana Masood; Shahid Hussain; Mashal Naeem; Sahar Fazal
Journal:  J Res Med Sci       Date:  2021-07-31       Impact factor: 1.852

Review 3.  Osteoid osteoma of the hip: imaging features.

Authors:  Jacques Malghem; Frederic Lecouvet; Thomas Kirchgesner; Souad Acid; Bruno Vande Berg
Journal:  Skeletal Radiol       Date:  2020-06-19       Impact factor: 2.199

4.  A preliminary comparative study of percutaneous CT-guided cryoablation with surgical resection for osteoid osteoma.

Authors:  Liangliang Meng; Xiao Zhang; Ruijiang Xu; Bin Wu; Xiaobo Zhang; Yingtian Wei; Jing Li; Husheng Shan; Yueyong Xiao
Journal:  PeerJ       Date:  2021-01-15       Impact factor: 2.984

5.  Weakening or Structural Strengthening? An Evaluation of Bone Density after MRgFUS Ablation for Treatment of Benign Bone Lesions.

Authors:  Camilla de Cataldo; Federico Bruno; Stefano Necozione; Mariangela Novello; Pierpaolo Palumbo; Luigi Zugaro; Antonio Barile; Carlo Masciocchi; Francesco Arrigoni
Journal:  J Clin Med       Date:  2021-12-29       Impact factor: 4.241

Review 6.  Interventional Radiology's Osteoid Osteoma Management: Percutaneous Thermal Ablation.

Authors:  Giampaolo Bianchi; Luigi Zugaro; Pierpaolo Palumbo; Roberto Candelari; Enrico Paci; Chiara Floridi; Andrea Giovagnoni
Journal:  J Clin Med       Date:  2022-01-29       Impact factor: 4.241

7.  Osteoid osteoma: treatment outcome and long-term follow-up after MRI-guided laser ablation.

Authors:  Ricarda Seemann; Georg Böning; Philipp Schwabe; Ulf Teichgräber; Bernhard Gebauer; Florian Streitparth
Journal:  Ann Transl Med       Date:  2022-03

8.  Avoiding Misdiagnosis and Missed Diagnosis for Appropriately Treating Spinal Osteoid Osteomas: A Single-Center Experience.

Authors:  Qiming Xu; Wensheng Liu; Hairong Xu; Lijia Cui; Yuan Li; Huachao Shan; Zhen Huang; Ke Ma; Xiaohui Niu
Journal:  Orthop Surg       Date:  2022-04-18       Impact factor: 2.279

Review 9.  Osteoid osteoma: which is the best mininvasive treatment option?

Authors:  Anna Parmeggiani; Claudia Martella; Luca Ceccarelli; Marco Miceli; Paolo Spinnato; Giancarlo Facchini
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-04-11

Review 10.  Comparison of arthroscopy versus percutaneous radiofrequency thermal ablation for the management of intra- and juxta-articular elbow osteoid osteoma: case series and a literature review.

Authors:  Igor Knežević; Ivan Bojanić
Journal:  BMC Musculoskelet Disord       Date:  2022-03-25       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.